Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 55 results for "yeda research development company"

TxCell 2015 Results and Update on Strategy and Outlook

VALBONNE, France--( BUSINESS WIRE )--Regulatory News: TxCell SA (Paris:TXCL) (FR0010127662 TXCL), a biotechnology company developing innovative, personalized cell immunotherapies using regulatory T-cells for the treatment of severe chronic ... Business Wire, 1 month ago
[x]  
Jerusalem Post

Merck and Weizmann Institute ink deal

Merck, the leading healthcare, life sciences and technology company established in Germany in 1668, extended its partnership with the Weizmann Institute of Science in Rehovot on Tuesday by signing a new framework agreement that builds on a ...
 Jerusalem Post2 months ago MERCK KGAA : and Weizmann Institute Sign New Framework Agreement on Research Collaboration  4 Traders2 months ago MERCK : and Weizmann Institute Sign New Framework Agreement on Research Collaboration  4 Traders2 months ago

Global Biotherapeutics Market Report: Novel Formulation and Delivery Approaches with Focus on Antibodies and Proteins - Research and Markets

/PRNewswire/ Research and Markets has announced the addition of the "Biotherapeutics: Novel Formulation and Delivery Approaches (Focus on Antibodies and Proteins)" report to their offering. Biopharmaceuticals is currently one of the fastest ...
 Pharmacy Choice4 weeks ago Biotherapeutics Market Report: Novel Formulation and Delivery Approaches - Focus on Antibodies and Proteins  Financial Buzz4 weeks ago Magnetic Resonance Imaging Systems Devices Market Research Assessment, 2015  Before It's News2 months ago Global Peptide Therapeutics in Metabolic Disorders 2016-2025  BioSpace2 months ago
[x]  
The Times Of Israel

Weizmann-developed drug may be speedy prostate cancer cure, studies show

Scientists at the Weizmann Institute may have found the cure for prostate cancer, at least if it is caught in its early stages via a drug that doctors inject into cancerous cells and treat with infrared laser illumination. Using a therapy ...
 The Times Of Israel3 weeks ago Revolutionary therapy for prostate cancer coming to Europe  Israel 21c2 weeks ago
American Banking News

BiondVax Pharma (BVXV) to Post FY2015 Earnings of ($0.03) Per Share, Zacks Investment Research Forecasts

BiondVax Pharma (NASDAQ:BVXV) Zacks Investment Research issued their FY2015 earnings per share estimates for BiondVax Pharma in a research note issued on Monday, according to Zacks Investment Research. Zacks Investment Research analyst D. Bautz ...
 American Banking News2 months ago Zacks Investment Research Reiterates Outperform Rating for BiondVax Pharma (BVXV)  WKRB News2 months ago

CELL SOURCE, INC. - 10-K - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

This Management Discussion and Analysis ("MD&A") contains "forward-looking statements," which represent our projections, estimates, expectations or beliefs concerning among other things, financial items that relate to management's future plans or ...
 Pharmacy Choice2 weeks ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less